Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-cell T-cell receptor repertoire profiling in dogs.
Hoang MH, Skidmore ZL, Rindt H, Chu S, Fisk B, Foltz JA, Fronick C, Fulton R, Zhou M, Bivens NJ, Reinero CN, Fehniger TA, Griffith M, Bryan JN, Griffith OL. Hoang MH, et al. Among authors: fehniger ta. Commun Biol. 2024 Apr 22;7(1):484. doi: 10.1038/s42003-024-06174-w. Commun Biol. 2024. PMID: 38649520 Free PMC article.
T-BET and EOMES sustain mature human NK cell identity and antitumor function.
Wong P, Foltz JA, Chang L, Neal CC, Yao T, Cubitt CC, Tran J, Kersting-Schadek S, Palakurty S, Jaeger N, Russler-Germain DA, Marin ND, Gang M, Wagner JA, Zhou AY, Jacobs MT, Foster M, Schappe T, Marsala L, McClain E, Pence P, Becker-Hapak M, Fisk B, Petti AA, Griffith OL, Griffith M, Berrien-Elliott MM, Fehniger TA. Wong P, et al. Among authors: fehniger ta. J Clin Invest. 2023 Jul 3;133(13):e162530. doi: 10.1172/JCI162530. J Clin Invest. 2023. PMID: 37279078 Free PMC article.
Donor-Derived Follicular Lymphoma After Kidney Transplantation: A Case Report.
Singhal K, Watkins MP, Fehniger TA, Griffith M, Griffith OL, Kahl BS, Russler-Germain DA. Singhal K, et al. Among authors: fehniger ta. JCO Precis Oncol. 2023 Sep;7:e2300177. doi: 10.1200/PO.23.00177. JCO Precis Oncol. 2023. PMID: 37824796 Free PMC article. No abstract available.
Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot Studies.
Patel DA, Wan F, Trinkaus K, Guy DG, Edwin N, Watkins M, Bartlett NL, Cashen A, Fehniger TA, Ghobadi A, Shah NM, Kahl BS. Patel DA, et al. Among authors: fehniger ta. Clin Lymphoma Myeloma Leuk. 2023 Jul;23(7):552-560. doi: 10.1016/j.clml.2023.04.003. Epub 2023 Apr 24. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37183115
A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell Lymphomas.
Foley N, Riedell PA, Bartlett NL, Cashen AF, Kahl BS, Fehniger TA, Fischer A, Moreno C, Liu J, Carson KR, Mehta-Shah N. Foley N, et al. Among authors: fehniger ta. Clin Lymphoma Myeloma Leuk. 2024 Dec 4:S2152-2650(24)02436-4. doi: 10.1016/j.clml.2024.11.015. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39725584
Engineering human pluripotent stem cell lines to evade xenogeneic transplantation barriers.
Pizzato HA, Alonso-Guallart P, Woods J, Connelly JP, Fehniger TA, Atkinson JP, Pruett-Miller SM, Monsma FJ Jr, Bhattacharya D. Pizzato HA, et al. Among authors: fehniger ta. Stem Cell Reports. 2024 Feb 13;19(2):299-313. doi: 10.1016/j.stemcr.2023.12.003. Epub 2024 Jan 11. Stem Cell Reports. 2024. PMID: 38215755 Free PMC article.
Nuclear EGFR in breast cancer suppresses NK cell recruitment and cytotoxicity.
Escoto A, Hecksel R, Parkinson C, Crane S, Atwell B, King S, Ortiz Chavez D, Jannuzi A, Sands B, Bitler BG, Fehniger TA, Paek AL, Padi M, Schroeder J. Escoto A, et al. Among authors: fehniger ta. Oncogene. 2024 Nov 9. doi: 10.1038/s41388-024-03211-0. Online ahead of print. Oncogene. 2024. PMID: 39521886
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma.
Fehniger TA, Watkins MP, Ezenwajiaku N, Wan F, Hurd DD, Cashen AF, Blum KA, Goy A, Fenske TS, Wagner-Johnston ND, Carson K, Siegel MJ, Russler-Germain D, Schneider SE, Mehta-Shah N, Kahl B, Bartlett NL. Fehniger TA, et al. Haematologica. 2024 Mar 1;109(3):953-957. doi: 10.3324/haematol.2022.282246. Haematologica. 2024. PMID: 37706336 Free PMC article. Clinical Trial. No abstract available.
MicroRNA-146a deficiency enhances host protection against murine cytomegalovirus.
Wong P, Leong JW, Sohn H, Chang L, Keppel CR, Neal CC, Cubitt CC, Yao T, Keppel MP, Tran J, Burdi A, Hwang K, Fogel LA, Schappe T, Marsala L, Berrien-Elliott MM, Wagner JA, Schneider SE, Sullivan RP, Pingel JT, Cooper MA, French AR, Fehniger TA. Wong P, et al. Among authors: fehniger ta. Eur J Immunol. 2024 Dec;54(12):e2451173. doi: 10.1002/eji.202451173. Epub 2024 Sep 9. Eur J Immunol. 2024. PMID: 39246120
A "Prime and Expand" strategy using the multifunctional fusion proteins to generate memory-like NK cells for cell therapy.
Shrestha N, Dee MJ, Chaturvedi P, Leclerc GM, Mathyer M, Dufour C, Arthur L, Becker-Hapak M, Foster M, McClain E, Pena NV, Kage K, Zhu X, George V, Liu B, Egan J, Echeverri C, Wang M, You L, Kong L, Li L, Berrien-Elliott MM, Cooper ML, Fehniger TA, Rhode PR, Wong HC. Shrestha N, et al. Among authors: fehniger ta. Cancer Immunol Immunother. 2024 Jul 3;73(9):179. doi: 10.1007/s00262-024-03765-8. Cancer Immunol Immunother. 2024. PMID: 38960949 Free PMC article.
154 results